Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference in London
Emergent BioSolutions Inc. (NYSE: EBS) will be webcasting its presentation at the Jefferies 2011 Global Healthcare Conference in London on Tuesday, September 27, 2011 at 3:40 PM BST. During the presentation, a member of the company’s management team will provide a corporate overview, which may include a discussion of the company’s business activities and financial [...]
September 21, 2011
Tags: Business, Chief executive officer, Emergent BioSolutions, Global Healthcare Conference Posted in: Chief executive officer, Emergent BioSolutions, Healthcare Conference, fuad el-hibri
No Comments
Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference
ROCKVILLE, Md., May 25, 2011 — Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the Jefferies 2011 Global Healthcare Conference in New York on Tuesday, June 7, 2011 at 1:15 PM Eastern. During the presentation, a member of the company’s senior management team will provide a corporate [...]
June 1, 2011
Tags: Business, Chief executive officer, Emergent BioSolutions, fuad el-hibri, Management, Webcast Posted in: Business, El-Hibri, Financial Performance, Healthcare Conference, Investors, fuad el-hibri
No Comments
Emergent BioSolutions Reports Financial Results for Full Year 2010
2010 revenues of $286.2 million
2010 net income of $51.7 million, or $1.63 per share, representing ninth consecutive year of profitability
2010 cash, investments and accounts receivable balance of $210.4 million
2011 forecast reaffirmed: total revenues of $320 to $340 million and net income of $35 to $45 million
Emergent BioSolutions Inc. (NYSE: EBS) announced on 10 March its [...]
April 13, 2011
Tags: Anthrax vaccines, Biothrax, Business, Chief financial officer, Emergent BioSolutions, Financial Results Posted in: Board of Directors, Business, Chief executive officer, Emergent BioSolutions, Financial Results, fuad el-hibri
No Comments
Emergent BioSolutions to Present Today at Needham & Company Healthcare Conference
Emergent BioSolutions Inc. (NYSE: EBS) will be webcasting its presentation at the 10th Annual Needham & Company Healthcare Conference in New York on Tuesday, April 5, 2011 at 8:00 AM Eastern. During the presentation, a member of the company’s senior management team will provide a corporate overview, which may include a discussion of [...]
April 5, 2011
Tags: Business, Chief executive officer, Emergent BioSolutions, fuad el-hibri, Needham & Company Healthcare Conference Posted in: Board of Directors, El-Hibri, Emergent BioSolutions, Healthcare Conference, fuad, fuad el-hibri
No Comments
Emergent BioSolutions to Release Fourth Quarter and Full Year 2010 Financial Results and Conduct a Conference Call on March 10, 2011
ROCKVILLE, Md., Feb 24, 2011 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced today it will report financial results for the fourth quarter and full year 2010 on Thursday, March 10, 2011, after market close.
Company management will host a conference call at 5:00 pm Eastern on March 10, 2011 to discuss [...]
February 25, 2011
Tags: Biotechnology and Pharmaceuticals, Business, Chief executive officer, Emergent BioSolutions, Infectious disease, Pharmaceuticals Posted in: Biotechnology and Pharmaceuticals, CEO, Emergent BioSolutions, Research and development, fuad el-hibri
No Comments
Emergent BioSolutions to Participate in June 2010 Investor Conferences
Fuad El-Hibri, CEO of Emergent BioSolutions Inc., announces that the company will be participating in the following investor conferences during June 2010:
The Jefferies & Company 2010 Global Life Sciences Conference
New [...]
June 7, 2010
Tags: Business, Emergent BioSolutions Inc., fuad el-hibri, Healthcare Conference, Jefferies & Company, United States., Webcast Posted in: Business, Emergent BioSolutions, Health Care, Healthcare Conference, fuad el-hibri
No Comments
Emergent BioSolutions Recognized as Biotechnology Firm of the Year by Tech Council of Maryland
ROCKVILLE, MD, May 13, 2010 – Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has been named Biotechnology Firm of the Year at the Tech Council of Maryland’s (TCM) Annual Tech Awards. This award acknowledges the company that best exemplifies the spirit of Maryland’s biotechnology community as well as its presence and leadership within the [...]
May 18, 2010
Tags: Business, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, fuad el-hibri, Research and development, Tech Council of Maryland Posted in: CEO, Department of Health and Human Services, Emergent BioSolutions, Research and development, Tech Council of Maryland, fuad el-hibri
No Comments
Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader
ROCKVILLE, Md., Mar 11, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (EBS 15.96, -0.03, -0.19%) announced today that Fuad El-Hibri, its chairman and chief executive officer, has been named by the World Trade Center Institute (WTCI) as one of Maryland’s outstanding international business leaders. Celebrating the spirit of global ambition and excellence in international leadership, [...]
March 15, 2010
Tags: Business, Chief executive officer, Emergent BioSolutions, fuad el-hibri, Leadership, Maryland Posted in: Biosolutions, Business, Emergent BioSolutions, Management
No Comments
Lebanese CEO Sees Opportunity in Current Crisis
Daily Star
July 10, 2009
http://www.dailystar.com.lb/article.asp?edition_id=1&categ_id=3&article_
id=104008
Chairman and CEO Fouad El Hibri insists that good business opportunities often arise in time of crisis, which he considers the best time for entrepreneurs to invest in new projects. “When the market is down, I believe that good opportunities arise and investors have better chances to find assets that are undervalued [...]
October 14, 2009
Tags: Business, Chairman, Crisis, entrepreneur, Lebanese, Opportunity Posted in: CEO, Crisis, Lebanese, Washington, entrepreneur, technology
No Comments
Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript
Emergent BioSolutions Inc., (EBS)
Q2 2009 Earnings Call
August 6, 2009 5:00 pm ET
Executives
Robert G. Burrows – Vice President, Investor Relations
Fuad El-Hibri – Chairman of the Board, Chief Executive Officer
R. Don Elsey – Chief Financial Officer
Daniel J. Abdun-Nabi – President, Chief Operating Officer
W. James Jackson, Ph.D. – Senior Vice President and Chief Scientific Officer
Analysts
Eric Schmidt [...]
August 14, 2009
Tags: Business, Chairman, Chief executive officer, Chief financial officer, Chief operating officer, Emergent BioSolutions, finance, fuad el-hibri, Investor relations, Shareholders, US government, Vice president Posted in: Board of Directors, CEO, Emergent BioSolutions, Management, Shareholders, fuad, fuad el-hibri
No Comments
